Research programme: NMDA antagonists - Wyeth

Drug Profile

Research programme: NMDA antagonists - Wyeth

Alternative Names: EAA 129; WAY 209129

Latest Information Update: 03 Oct 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wyeth
  • Class 2 ring heterocyclic compounds; Benzoates; Phosphoric acid esters
  • Mechanism of Action NMDA receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Pain

Most Recent Events

  • 07 Aug 2009 No development reported - Preclinical for Pain in United Kingdom (PO)
  • 30 May 2006 Preclinical development for Pain in the USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top